Syquant Capital Sas Pacific Biosciences Of California, Inc. Transaction History

Syquant Capital Sas

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 17, 2019	SELL	$4.99 - $6.16 $3.55 Million - $4.39 Million	-712,227 Closed	0 $0
Q2 2019 Jul 05, 2019	BUY	$5.92 - $7.41 $1.28 Million - $1.6 Million	216,101 Added 43.56%	712,227 $4.31 Million
Q1 2019 Apr 12, 2019	BUY	$6.8 - $7.4 $3.37 Million - $3.67 Million	496,126 New	496,126 $3.59 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Syquant Capital Sas, based on Form 13F filings with the SEC.

Stay updated on Syquant Capital Sas with notifications on news.